Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Jul;8(7):737-738.
doi: 10.1002/sctm.19-0050. Epub 2019 Mar 29.

Use of Bone Marrow-Derived Mesenchymal Stem Cells in Prostate Cancer Could Increase the Risk of Cancer Progression

A Thirumal Raj  1 , Supriya Kheur  1 , Ramesh Bhonde  2 , Archana A Gupta  1 , Vikrant R Patil  3 , Avinash Kharat  3
Affiliations
Comment

Use of Bone Marrow-Derived Mesenchymal Stem Cells in Prostate Cancer Could Increase the Risk of Cancer Progression

A Thirumal Raj et al. Stem Cells Transl Med. 2019 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors indicated no potential conflicts of interest.

Figures

Figure 1
Figure 1
Bone marrow‐derived mesenchymal stem cell‐mediated progression of prostate cancer.
See this image and copyright information in PMC

Comment in

  • In Reply.
    Brennen WN, Schweizer MT, Wang H, Bivalacqua TJ, Partin AW, Lim SJ, Chapman C, Abdallah R, Levy O, Bhowmick NA, Karp JM, De Marzo A, Isaacs JT, Denmeade SR. Brennen WN, et al. Stem Cells Transl Med. 2019 Jul;8(7):739-740. doi: 10.1002/sctm.19-0068. Epub 2019 Mar 29. Stem Cells Transl Med. 2019. PMID: 30925030 Free PMC article. No abstract available.

Comment on

References

    1. Schweizer MT, Wang H, Bivalacqua TJ et al. A phase I study to assess the safety and cancer‐homing ability of allogeneic bone marrow‐derived mesenchymal stem cells in men with localized prostate cancer. Stem Cells Translational Medicine 2019;8:441–449. - PMC - PubMed
    1. Raj AT, Kheur S, Patil VR et al. Assessing the role of cell fusion in cancer metastasis. Oral Oncol 2019;90:124–125. - PubMed
    1. Raj AT, Kheur S. Hypothesizing the potential implications of exposing known carcinogens on normal stem cells. Oral Oncol 2018;79:86–87. - PubMed
    1. Raj AT, Kheur S, Gupta AA et al. The need for combination immunotherapy in oncology. Oral Oncol 2019. 10.1016/j.oraloncology.2019.02.013. - DOI - PubMed
    1. Papaccio F, Paino F, Regad T et al. Concise review: Cancer cells, cancer stem cells, and mesenchymal stem cells: Influence in cancer development. Stem Cells Translational Medicine 2017;6:2115–2125. - PMC - PubMed